Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Killer Cells, Lymphokine-Activated

"Killer Cells, Lymphokine-Activated" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

Cytolytic lymphocytes with the unique capacity of killing natural killer (NK)-resistant fresh tumor cells. They are INTERLEUKIN-2-activated NK cells that have no MAJOR HISTOCOMPATIBILITY COMPLEX restriction or need for antigen stimulation. LAK cells are used for ADOPTIVE IMMUNOTHERAPY in cancer patients.


This graph shows the total number of publications written about "Killer Cells, Lymphokine-Activated" by people in Harvard Catalyst Profiles by year, and whether "Killer Cells, Lymphokine-Activated" was a major or minor topic of these publication.
Bar chart showing 41 publications over 16 distinct years, with a maximum of 7 publications in 1990 and 1992
To see the data from this visualization as text, click here.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.